» Articles » PMID: 31354271

Ultrasmall Superparamagnetic Nanoparticles Targeting E-selectin: Synthesis and Effects in Mice in Vitro and in Vivo

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2019 Jul 30
PMID 31354271
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We developed a contrast agent for targeting E-selectin expression. We detected the agent using magnetic resonance imaging (MRI) in vivo in nude mice that had undergone nasopharyngeal carcinoma (NPC) metastasis. Sialyl Lewis X (sLe) was conjugated with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. Hydrodynamic size, polydispersity index, and ζ-potential of USPIO-polyethylene glycol (PEG) nanoparticles and USPIO-PEG-sLe nanoparticles were measured. Component changes in nanoparticles of USPIO, USPIO-PEG, and USPIO-PEG-sLe were analyzed by thermogravimetric analysis and Fourier-transform infrared spectroscopy. A model of NPC metastasis to inguinal lymph nodes in nude mice was used to investigate characteristics of the USPIO-PEG-sLe nanoparticles in vivo. We investigated the ability of the T2* value, change in T2* value (ΔT2* value), and enhancement rate (ER) to assess accumulation of USPIO-PEG-sLe nanoparticles quantitatively in mice of a metastasis group and control group. Four MRI scans were undertaken for each mouse. The first scan (t0) was done before administration of USPIO-PEG-sLe nanoparticles (0.1 mL) via the tail vein. The other scans were carried out at 0 (t1), 1 (t2), and 2 hours (t3) postinjection. The mean optical density was used to reflect E-selectin expression. sLe was labeled onto USPIO successfully. In vivo, there were significant interactions between the groups and time for T2* values after administration of USPIO-PEG-sLe nanoparticles. Six parameters (T2* at t2, ΔT2* at t1, ΔT2* at t2, ER at t1, ER at t2, and ER at t3) were correlated with the mean optical density. USPIO-PEG-sLe nanoparticles can be used to assess E-selectin expression quantitatively. Use of such molecular probes could enable detection of early metastasis of NPC, more accurate staging, and treatment monitoring.

Citing Articles

Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer.

Song Q, Zheng Y, Zhong G, Wang S, He C, Li M Anticancer Agents Med Chem. 2024; 24(18):1305-1326.

PMID: 39129164 PMC: 11497148. DOI: 10.2174/0118715206323900240807110122.


Superparamagnetic Iron Oxide-Erastin-Polyethylene Glycol Nanotherapeutic Platform: A Ferroptosis-Based Approach for the Integrated Diagnosis and Treatment of Nasopharyngeal Cancer.

Tang H, Zhou X, Liu L, Wang Z, Wang C, Luo N Mol Pharm. 2024; 21(6):2767-2780.

PMID: 38736196 PMC: 11152051. DOI: 10.1021/acs.molpharmaceut.3c01172.


Precision USPIO-PEG-SLe Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance.

Li T, Guo L, Li J, Mu X, Liu L, Song S Int J Nanomedicine. 2024; 19:1249-1272.

PMID: 38348177 PMC: 10859766. DOI: 10.2147/IJN.S445879.


Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions.

Ji H, Hu C, Yang X, Liu Y, Ji G, Ge S Signal Transduct Target Ther. 2023; 8(1):367.

PMID: 37752146 PMC: 10522642. DOI: 10.1038/s41392-023-01576-4.


Functional roles of magnetic nanoparticles for the identification of metastatic lymph nodes in cancer patients.

Yan Y, Liu Y, Li T, Liang Q, Thakur A, Zhang K J Nanobiotechnology. 2023; 21(1):337.

PMID: 37735449 PMC: 10512638. DOI: 10.1186/s12951-023-02100-0.


References
1.
Taylor A, Panting J, Keegan J, Gatehouse P, Amin D, Jhooti P . Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. J Magn Reson Imaging. 1999; 9(2):220-7. DOI: 10.1002/(sici)1522-2586(199902)9:2<220::aid-jmri11>3.0.co;2-a. View

2.
Weissleder R, Mahmood U . Molecular imaging. Radiology. 2001; 219(2):316-33. DOI: 10.1148/radiology.219.2.r01ma19316. View

3.
Anderson L, Holden S, Davis B, Prescott E, Charrier C, Bunce N . Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2002; 22(23):2171-9. DOI: 10.1053/euhj.2001.2822. View

4.
Kaila N, Thomas 4th B . Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors. Med Res Rev. 2002; 22(6):566-601. DOI: 10.1002/med.10018. View

5.
Zhang B, Chen H, Yao X, Cong W, Wu M . E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2003; 1(1):80-2. View